Home » Topics » BioWorld Science

BioWorld Science
RSS

Notch1 as a promising new therapeutic target in multiple myeloma

July 1, 2019

Phase II results presented for pazopanib in patients with progressive carcinoid tumors

July 1, 2019

MolMed suspends enrollment of new patients in phase III TK008 study of Zalmoxis

July 1, 2019

ImmusanT discontinues phase II study of Nexvax2 in celiac disease

July 1, 2019

Bayer initiates phase II AVANTI study of BAY-1753011 in congestive heart failure

July 1, 2019

AptaTargets initiates first-in-human trial of ApTOLL

July 1, 2019

BR-11257, a novel nonstabilizing soluble guanylyl cyclase partial agonist

July 1, 2019

A novel androgen receptor antagonist is a promising candidate for enzalutamide-resistant CRPC

July 1, 2019

IDEAYA Biosciences initiates phase I/II study of IDE-196

July 1, 2019

ImmuPharma reports open-label extension study results for Lupuzor in SLE

June 28, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...